← Leaderboards
James H Doroshow
City Of Hope/Beckman Research Institute
$6,200,078
Attributed
$6,200,078
Total exposure
9
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$6,200,078 · 9
By mechanism
U01$2,088,883 · 2
K12$1,824,874 · 1
U10$996,378 · 1
U09$806,000 · 1
R01$301,011 · 1
M01$182,932 · 3
Top collaborators
No co-investigators on record.
Most similar at City Of Hope/Beckman Research Institute
Same institution · by research overlap
- Lucille Leong$684,227
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectNeoplasm /Cancer ChemotherapyHuman Therapy EvaluationAntineoplasticsClinical ResearchClinical TrialsPaclitaxelPharmacokineticsCancer Registry /ResourceTissue Resource /RegistryCooperative StudyBreast NeoplasmsDrug Screening /EvaluationBiopsyCombination Cancer TherapyLung NeoplasmsNeoplasm /Cancer PharmacologyCyclophosphamideBone Marrow TransplantationGastrointestinal NeoplasmsBleomycinGene ExpressionDrug ResistanceCancer Prevention
Grant awards (20)
PHI-39: Phase I Trial of #7389 (Halichondrin B Analog)$162,607
M01 · FY2004 · RR
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS$92,736
U10 · FY2004 · CA
A Phase I Pharmacokinetic Study of STI-571 in Patients$10,697
M01 · FY2004 · RR
A Phase I Pharmacokinetic Study of STI-571 in Patients$9,628
M01 · FY2004 · RR
Oncology Research Career Development Program$538,380
K12 · FY2003 · CA
Phase I Molecular and Clinical Pharmacodynamic Trials$518,925
U01 · FY2003 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS$370,946
U10 · FY2003 · CA
PHASE I MOLECULAR AND CLINICAL PHARMACODYNAMIC TRIALS$418,681
U01 · FY2002 · CA
MDR1 GENE THERAPY IN CD34+ CELLS AND SCID MICE$301,011
R01 · FY2002 · CA
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM$290,734
K12 · FY2002 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS$212,396
U10 · FY2002 · CA
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM$497,880
K12 · FY2001 · CA
PHASE I MOLECULAR AND CLINICAL PHARMACODYNAMIC TRIALS$406,740
U01 · FY2001 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS$162,518
U10 · FY2001 · CA
PHARMACODYNAMIC PHASE II BREAST, LUNG AND OVARY TRIALS$81,133
U01 · FY2001 · CA
NATIONAL CANCER INSTITUTE INITIAL REVIEW GROUP$806,000
U09 · FY2000 · CA
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM$497,880
K12 · FY2000 · CA
PHASE I MOLECULAR AND CLINICAL PHARMACODYNAMIC TRIALS$396,181
U01 · FY2000 · CA
PHARMACODYNAMIC PHASE II BREAST, LUNG AND OVARY TRIALS$267,223
U01 · FY2000 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS$157,782
U10 · FY2000 · CA